MTOR and type 2 diabetes mellitus: The translation repressor 4E-BP1 is a known substrate of the mTOR (Mechanistic Target of Rapamycin) signaling pathway, which regulates important cellular processes and is involved in several pathological conditions, including type 2 diabetes, obesity and cancer [29].